Author： McMillan Grant
Publisher： Adis International
ISSN： 1176-2551
Source： Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol.24, Iss.4, 2005-01, pp. : 237-257
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Dopaminergic substitution in Parkinson’s disease
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 10, 2002-10 ,pp. :
Dopamine agonists in Parkinson’s disease
By Tintner Ron Jankovic Joseph
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. :
Transplantation therapy for Parkinson’s disease
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. :
Ropinirole in the treatment of Parkinson’s disease
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. :